Viking Therapeutics Inc (VKTX)
76.97
+1.21
(+1.60%)
USD |
NASDAQ |
May 03, 16:00
76.97
0.00 (0.00%)
After-Hours: 20:00
Viking Therapeutics 1 Year Total Returns (Daily): 258.8% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 258.8% |
May 02, 2024 | 260.8% |
May 01, 2024 | 245.5% |
April 30, 2024 | 273.4% |
April 29, 2024 | 253.9% |
April 26, 2024 | 280.1% |
April 25, 2024 | 246.4% |
April 24, 2024 | 205.1% |
April 23, 2024 | 206.1% |
April 22, 2024 | 201.0% |
April 19, 2024 | 198.2% |
April 18, 2024 | 217.3% |
April 17, 2024 | 238.6% |
April 16, 2024 | 262.4% |
April 15, 2024 | 257.1% |
April 12, 2024 | 287.0% |
April 11, 2024 | 300.6% |
April 10, 2024 | 323.0% |
April 09, 2024 | 336.6% |
April 08, 2024 | 354.9% |
April 05, 2024 | 368.4% |
April 04, 2024 | 332.1% |
April 03, 2024 | 346.4% |
April 02, 2024 | 364.6% |
April 01, 2024 | 377.5% |
Date | Value |
---|---|
March 28, 2024 | 431.1% |
March 27, 2024 | 813.8% |
March 26, 2024 | 813.3% |
March 25, 2024 | 681.8% |
March 22, 2024 | 626.0% |
March 21, 2024 | 652.6% |
March 20, 2024 | 510.8% |
March 19, 2024 | 451.0% |
March 18, 2024 | 435.5% |
March 15, 2024 | 485.8% |
March 14, 2024 | 496.8% |
March 13, 2024 | 583.4% |
March 12, 2024 | 548.3% |
March 11, 2024 | 512.9% |
March 08, 2024 | 524.2% |
March 07, 2024 | 553.1% |
March 06, 2024 | 691.5% |
March 05, 2024 | 643.0% |
March 04, 2024 | 672.1% |
March 01, 2024 | 648.2% |
February 29, 2024 | 599.8% |
February 28, 2024 | 758.3% |
February 27, 2024 | 673.9% |
February 26, 2024 | 249.8% |
February 23, 2024 | 226.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.89%
Minimum
Sep 24 2019
992.5%
Maximum
Jun 13 2023
81.41%
Average
-13.13%
Median
Jun 30 2020
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 71.87% |
Pfizer Inc | -23.89% |
Madrigal Pharmaceuticals Inc | -24.59% |
Akero Therapeutics Inc | -56.33% |
Terns Pharmaceuticals Inc | -57.83% |